Study Splits Kidney Drug Advice

CambridgeWhich diabetes drug protects kidneys depends on how much damage is already done.

A 736,212-patient study found combination therapy cut deaths 46% in early kidney disease, versus 19% for GLP-1 drugs alone in advanced cases — an unreviewed manuscript, not a trial.

Cheaper SGLT-2 inhibitors are going generic; the finding matters most where diabetes and cost both run high.

Sources: Nature